NovaBay Pharmaceuticals News

NovaBay Pharmaceuticals | DEFA14A: Others

Oct 29 08:23 ET

NovaBay Pharmaceuticals | 8-K: Current report

Oct 29 08:18 ET

NovaBay Pharmaceuticals | 8-K: Current report

Oct 16 16:28 ET

NovaBay Pharmaceuticals | DEFM14A: Definitive proxy statement relating to merger or acquisition

Oct 16 16:23 ET

NovaBay Pharmaceuticals | PREM14A: Preliminary proxy statements relating to merger or acquisition

Sep 25 17:20 ET

NovaBay Pharmaceuticals | DEFA14A: Others

Sep 20 08:12 ET

NovaBay Pharmaceuticals | 8-K: Current report

Sep 20 08:12 ET

NovaBay Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 13 16:15 ET

NovaBay Pharmaceuticals | 8-K: Current report

Jul 29 16:30 ET

NovaBay Pharmaceuticals | 424B4: Prospectus

Jul 29 12:39 ET

NovaBay Pharmaceuticals | POS EX: Post-effective amendment filed solely to add exhibits to a registration statement

Jul 26 17:24 ET

NovaBay Pharmaceuticals | EFFECT: Others

Jul 26 06:09 ET

NovaBay Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Jul 25 12:39 ET

NovaBay Pharmaceuticals | CORRESP: CORRESP

Jul 22 22:17 ET

NovaBay Pharmaceuticals | CORRESP: CORRESP

Jul 22 22:17 ET

NovaBay Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Jul 15 12:44 ET

NovaBay Pharmaceuticals | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Jul 11 08:53 ET

NovaBay Pharmaceuticals | 8-K: Current report

Jul 11 08:48 ET

NovaBay Pharmaceuticals | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Jul 10 16:10 ET

NovaBay Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Jul 10 09:34 ET